Related Experiment Video
Updated: Nov 29, 2025

Field Identification of Matricaria chamomilla using a Portable qPCR System
Published on: October 10, 2020
Ethical considerations and challenges in herbal drug trials with the focus on scientific validity and risk assessment
Nut Koonrungsesomboon1,2, Nimit Morakote3, Juntra Karbwang4
1Department of Pharmacology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Abstract:
Scientific validity and risk assessment are two main ethical issues which raise specific challenges and are unique to clinical trials investigating crude extracts/fractions from herbal materials. There are considerable challenges for both clinical investigators and ethics committee members in dealing with such issues, many of them remain unresolved, resulting in a large variation in ethical requirements, justification, and decisions. Despite a remarkable surge in herbal medicine research globally, a number of clinical investigators or even ethics committee members have limited confidence in dealing with related ethical issues. In this article, we extensively review and discuss the two main ethical issues (i.e., scientific validity and risk assessment) and highlight key considerations that are important for ethical review and justification for the conduct of herbal drug trials.
More Related Videos
08:07Preparation of Herbal Medicine: Er-Xian Decoction and Er-Xian-containing Serum for In Vivo and In Vitro Experiments
Published on: May 31, 2017
11:38High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
Published on: May 10, 2016
Related Concept Videos
Drug Regulation
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Clinical Trials: Overview
Bioequivalence of Drugs: Drugs with Multiple Indications
Bioavailability Study Design: Healthy Subjects Versus Patients
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence